Last reviewed · How we verify

NCT05039749

Human Centric Lighting to Improve Patient Sleep Parameters

Completed NA Last updated 10 September 2021
What this trial tests

NA trial testing Human Centric Lights in Sleep Disturbance in 13 participants. Completed in 15 May 2021.

Timeline
1 November 2020
Primary endpoint
30 April 2021
15 May 2021

Quick facts

Lead sponsorLandstuhl Regional Medical Center
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposeother
Enrollment13
Start date1 November 2020
Primary completion30 April 2021
Estimated completion15 May 2021
Sites1 location across Germany

Drugs / interventions tested

Conditions studied

Sponsor

Landstuhl Regional Medical Center

Who can join

18 and older, any sex, with Sleep Disturbance. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Human centric lighting (HCL) is a technology that supports the body's circadian rhythm, as it can stimulate the sleep triggering hormone, melatonin, to improve sleep hygiene over standard lighting (SL), and promote recuperative sleep for a timely return-to-duty. In intensive care units, exposure to HCL has improved sleep measures. However, the effect in the medical surgical (MS) environment is unknown. The purpose of this study is to assess the feasibility of study procedures in MS setting and conduct a preliminary evaluation of the effect of light on inpatient sleep. Recruitment started November 2020 through April 2021. Data analysis is pending.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Sleep Disturbance

Currently open trials in the same condition.

Other Landstuhl Regional Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05039749.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing